.
619. Speziale F, Verardi S, Taurino M, Nicolini G, Rizzo L, Fiorani P,
et al. Low molecular weight heparin prevention of postoperative deep vein thrombosis in vascular surgery. Pharmatherapeutica 1988;5:261-8.
620. Farkas JC, Chapuis C, Combe S, Silsiguen M, Marzelle J,
Laurian C, et al. A randomised controlled trial of a lowmolecular-weight heparin (Enoxaparin) to prevent deepvein thrombosis in patients undergoing vascular surgery.
Eur J Vasc Surg 1993;7:554-60.
621. Lastoria S, Rollo HA, Yoshida WB, Giannini M, Moura R,
Maffei FH. Prophylaxis of deep-vein thrombosis after lower
extremity amputation: comparison of low molecular
weight heparin with unfractionated heparin. Acta Cir Bras
2006;21:184-6.
622. Obi AT, Park YJ, Bove P, Cuff R, Kazmers A, Gurm HS, et al.
The association of perioperative transfusion with 30-day

morbidity and mortality in patients undergoing major
vascular surgery. J Vasc Surg 2015;61:1000-9.e1.
623. Hebert PC, Carson JL. Transfusion threshold of 7 g per
deciliterdthe new normal. N Engl J Med 2014;371:1459-61.
624. Curley GF, Shehata N, Mazer CD, Hare GM, Friedrich JO.
Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis*.
Crit Care Med 2014;42:2611-24.
625. Carson JL, Carless PA, Hebert PC. Transfusion thresholds
and other strategies for guiding allogeneic red blood cell
transfusion. Cochrane Database Syst Rev 2012:CD002042.
62